AMRN

NASDAQ HEALTHCARE

Amarin Corporation PLC

$13.80

-$0.24 (-1.71%)

Live quote

52w: $12.96 – $20.90

Loading chart…

P/E Ratio—

P/B Ratio13.07

EV/EBITDA—

Debt/Equity—

ROE-8.75%

ROIC—

Revenue Growth-6.55%

Gross Margin56.57%

Amarin Corporation plc, a pharmaceutical company, is engaged in the development and commercialization of therapies for the treatment of cardiovascular disease in the United States. The company is headquartered in Dublin, Ireland.

Own AMRN? Track it here.

Create a free account to add AMRN to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account